Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 235

1.

Effects of CD4 monitoring frequency on clinical endpoints in clinically stable HIV-infected patients with viral suppression.

Ahn JY, Boettiger D, Law M, Kumarasamy N, Yunihastuti E, Chaiwarith R, Lee MP, Sim BL, Oka S, Wong W, Kamarulzaman A, Kantipong P, Phanuphak P, Ng OT, Kiertiburanakul S, Zhang F, Pujari S, Ditangco R, Ratanasuwan W, Merati TP, Saphonn V, Sohn AH, Choi JY.

J Acquir Immune Defic Syndr. 2015 Apr 4. [Epub ahead of print]

PMID:
25850606
2.

Differences in Evolution of HIV-1 Subtype C Reverse Transcriptase between Children and Adults Likely Explained by Maturity of Cytotoxic T-Lymphocyte Responses.

Saravanan S, Gomathi S, Kausalya B, Boobalan J, Murugavel KG, Pachamuthu B, Mothi SN, Solomon SS, Kumarasamy N, Poongulali S, Solomon S, Smith DM.

AIDS Res Hum Retroviruses. 2015 Apr 3. [Epub ahead of print]

PMID:
25839730
3.

Treatment of W. bancrofti (Wb) in HIV/Wb Coinfections in South India.

Talaat KR, Babu S, Menon P, Kumarasamy N, Sharma J, Arumugam J, Dhakshinamurthy K, Srinivasan R, Poongulali S, Gu W, Fay MP, Swaminathan S, Nutman TB.

PLoS Negl Trop Dis. 2015 Mar 20;9(3):e0003622. doi: 10.1371/journal.pntd.0003622. eCollection 2015 Mar.

4.

Impact of Gender on Long-Term Treatment Outcomes of Highly Active Antiretroviral Therapy (HAART) in the TREAT Asia HIV Observational Database.

Lee MP, Zhou J, Messerschmidt L, Honda M, Ditangco R, Sirisanthana T, Kumarasamy N, Phanuphak P, Chen YM, Zhang F, Saphonn V, Kiertiburanakul S, Lee CK, Pujari S, Choi JY, Kamarulzaman A, Yunihastuti E, Merati TP, Lim PL, Li PC.

AIDS Patient Care STDS. 2015 Mar 16. [Epub ahead of print] No abstract available.

PMID:
25774867
5.

Long term impact of antiretroviral therapy - Can we end HIV epidemic, the goal beyond 2015.

Kumarasamy N, Pendse R.

Indian J Med Res. 2014 Dec;140(6):701-3. No abstract available.

6.

Raltegravir non-inferior to nucleoside based regimens in second-line therapy with lopinavir/ritonavir over 96 weeks: a randomised open label study for the treatment of HIV-1 infection.

Amin J, Boyd MA, Kumarasamy N, Moore CL, Losso MH, Nwizu CA, Mohapi L, Kerr SJ, Sohn AH, Teppler H, Renjifo B, Molina JM, Emery S, Cooper DA.

PLoS One. 2015 Feb 27;10(2):e0118228. doi: 10.1371/journal.pone.0118228. eCollection 2015.

7.

Safety and Efficacy of Darunavir/Ritonavir in Treatment-experienced Pediatric Patients: Week 48 Results of the ARIEL Trial.

Violari A, Bologna R, Kumarasamy N, Pilotto JH, Hendrickx A, Kakuda TN, Lathouwers E, Opsomer M, Van de Casteele T, Tomaka FL.

Pediatr Infect Dis J. 2015 May;34(5):e132-7. doi: 10.1097/INF.0000000000000644.

PMID:
25719453
8.

C-reactive protein (CRP), interferon gamma-inducible protein 10 (IP-10), and lipopolysaccharide (LPS) are associated with risk of tuberculosis after initiation of antiretroviral therapy in resource-limited settings.

Tenforde MW, Gupte N, Dowdy DW, Asmuth DM, Balagopal A, Pollard RB, Sugandhavesa P, Lama JR, Pillay S, Cardoso SW, Pawar J, Santos B, Riviere C, Mwelase N, Kanyama C, Kumwenda J, Hakim JG, Kumarasamy N, Bollinger R, Semba RD, Campbell TB, Gupta A; ACTG PEARLS and NWCS 319 Study Group.

PLoS One. 2015 Feb 26;10(2):e0117424. doi: 10.1371/journal.pone.0117424. eCollection 2015.

9.

Lopinavir/Ritonavir Monotherapy as Second-line Antiretroviral Treatment in Resource-Limited Settings: Week 104 Analysis of AIDS Clinical Trials Group (ACTG) A5230.

Kumarasamy N, Aga E, Ribaudo HJ, Wallis CL, Katzenstein DA, Stevens WS, Norton MR, Klingman KL, Hosseinipour MC, Crump JA, Supparatpinyo K, Badal-Faesen S, Bartlett JA.

Clin Infect Dis. 2015 Feb 18. pii: civ109. [Epub ahead of print]

PMID:
25694653
10.

Pretreatment HIV Drug Resistance and HIV-1 Subtype C Are Independently Associated With Virologic Failure: Results From the Multinational PEARLS (ACTG A5175) Clinical Trial.

Kantor R, Smeaton L, Vardhanabhuti S, Hudelson SE, Wallis CL, Tripathy S, Morgado MG, Saravanan S, Balakrishnan P, Reitsma M, Hart S, Mellors JW, Halvas E, Grinsztejn B, Hosseinipour MC, Kumwenda J, La Rosa A, Lalloo UG, Lama JR, Rassool M, Santos BR, Supparatpinyo K, Hakim J, Flanigan T, Kumarasamy N, Campbell TB, Eshleman SH; for the AIDS Clinical Trials Group (ACTG) A5175 Study Team.

Clin Infect Dis. 2015 Feb 13. pii: civ102. [Epub ahead of print]

PMID:
25681380
11.

The future role of CD4 cell count for monitoring antiretroviral therapy.

Ford N, Meintjes G, Pozniak A, Bygrave H, Hill A, Peter T, Davies MA, Grinsztejn B, Calmy A, Kumarasamy N, Phanuphak P, deBeaudrap P, Vitoria M, Doherty M, Stevens W, Siberry GK.

Lancet Infect Dis. 2015 Feb;15(2):241-7. doi: 10.1016/S1473-3099(14)70896-5. Epub 2014 Nov 19.

PMID:
25467647
12.

Renal and metabolic toxicities following initiation of HIV-1 treatment regimen in a diverse, multinational setting: a focused safety analysis of ACTG PEARLS (A5175).

Touzard Romo F, Smeaton LM, Campbell TB, Riviere C, Mngqibisa R, Nyirenda M, Supparatpinyo K, Kumarasamy N, Hakim JG, Flanigan TP.

HIV Clin Trials. 2014 Nov-Dec;15(6):246-60. doi: 10.1310/hct1506-246.

13.

A clinical prediction tool for targeted pre-antiretroviral therapy creatinine testing applied to the TREAT Asia HIV observational database cohort.

Boettiger DC, Saphonn V, Lee MP, Phanuphak P, Pham TT, Heng Sim BL, Kumarasamy N, Van Nguyen K, Kantipong P, Kamarulzaman A, Chaiwarith R, Kiertiburanakul S, Law MG.

J Acquir Immune Defic Syndr. 2014 Dec 1;67(4):e131-3. doi: 10.1097/QAI.0000000000000338. No abstract available.

PMID:
25197829
14.

Trends in first-line antiretroviral therapy in Asia: results from the TREAT Asia HIV observational database.

Boettiger DC, Kerr S, Ditangco R, Merati TP, Pham TT, Chaiwarith R, Kiertiburanakul S, Li CK, Kumarasamy N, Vonthanak S, Lee C, Van Kinh N, Pujari S, Wong WW, Kamarulzaman A, Zhang F, Yunihastuti E, Choi JY, Oka S, Ng OT, Kantipong P, Mustafa M, Ratanasuwan W, Sohn A, Law M.

PLoS One. 2014 Sep 3;9(9):e106525. doi: 10.1371/journal.pone.0106525. eCollection 2014.

15.

Psychosocial predictors of non-adherence and treatment failure in a large scale multi-national trial of antiretroviral therapy for HIV: data from the ACTG A5175/PEARLS trial.

Safren SA, Biello KB, Smeaton L, Mimiaga MJ, Walawander A, Lama JR, Rana A, Nyirenda M, Kayoyo VM, Samaneka W, Joglekar A, Celentano D, Martinez A, Remmert JE, Nair A, Lalloo UG, Kumarasamy N, Hakim J, Campbell TB; PEARLS (ACTG A5175) Study Team.

PLoS One. 2014 Aug 25;9(8):e104178. doi: 10.1371/journal.pone.0104178. eCollection 2014.

16.

HIV prevention in clinical care settings: 2014 recommendations of the International Antiviral Society-USA Panel.

Marrazzo JM, del Rio C, Holtgrave DR, Cohen MS, Kalichman SC, Mayer KH, Montaner JS, Wheeler DP, Grant RM, Grinsztejn B, Kumarasamy N, Shoptaw S, Walensky RP, Dabis F, Sugarman J, Benson CA; International Antiviral Society-USA Panel.

JAMA. 2014 Jul 23-30;312(4):390-409. doi: 10.1001/jama.2014.7999. Erratum in: JAMA. 2014 Jul 23-30;312(4):403. JAMA. 2014 Aug 13;312(6):652.

PMID:
25038358
17.

Dropout from care among HIV-infected patients enrolled in care at a tertiary HIV care center in Chennai, India.

Blutinger EJ, Solomon S, Srikrishnan AK, Thamburaj E, Kumarasamy N, Balakrishnan P, Anand S, Ganesh AK, Solomon SS.

AIDS Care. 2014;26(12):1500-5. doi: 10.1080/09540121.2014.934654. Epub 2014 Jul 11.

PMID:
25011519
18.

Commentary: The monitoring of adults and children on antiretroviral therapy in the 2013 WHO consolidated ARV guidelines.

Essajee S, Kumarasamy N.

AIDS. 2014 Mar;28 Suppl 2:S147-9. doi: 10.1097/QAD.0000000000000238. No abstract available.

PMID:
24849474
19.

Factors associated with suboptimal adherence to antiretroviral therapy in Asia.

Jiamsakul A, Kumarasamy N, Ditangco R, Li PC, Phanuphak P, Sirisanthana T, Sungkanuparph S, Kantipong P, K C Lee C, Mustafa M, Merati T, Kamarulzaman A, Singtoroj T, Law M; TREAT Asia Studies to Evaluate Resistance Monitoring Study (TASER-M).

J Int AIDS Soc. 2014 May 16;17:18911. doi: 10.7448/IAS.17.1.18911. eCollection 2014.

20.

25-Hydroxyvitamin D insufficiency and deficiency is associated with HIV disease progression and virological failure post-antiretroviral therapy initiation in diverse multinational settings.

Havers F, Smeaton L, Gupte N, Detrick B, Bollinger RC, Hakim J, Kumarasamy N, Andrade A, Christian P, Lama JR, Campbell TB, Gupta A; ACTG PEARLS; NWCS 319 Study Teams.

J Infect Dis. 2014 Jul 15;210(2):244-53. doi: 10.1093/infdis/jiu259. Epub 2014 May 5.

PMID:
24799602
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk